reviewTop 1% cited
Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries
Vaccine · 2008 · Vol. 26 · pp. K29–K41
Jack Cuzick✉(Cancer Research UK)Marc Arbyn(Institut Scientifique de Santé Publique)Rengaswamy Sankaranarayanan(Centre International de Recherche sur le Cancer)Vivien Tsu(Program for Appropriate Technology in Health)Guglielmo Ronco(Piedmont Reference Center for Epidemiology and Cancer Prevention)Marie‐Hélène Mayrand(Université de Montréal)Joakim Dillner(Lund University)Chris J.L.M. Meijer(Vrije Universiteit Amsterdam)
Cervical Cancer and HPV ResearchGenital Health and DiseaseColposcopyTriageMedicineCervical cancerCervical intraepithelial neoplasiaPopulationGynecologyObstetricsCytologyCancer
MeSH terms
Uterine Cervical NeoplasmsCervix UteriDeveloping CountriesFemaleHumansMass ScreeningDeveloped CountriesPapillomaviridaePapillomavirus Infections
Citations
647
FWCI
37.31
field-weighted impact
References
51
Percentile
100%
vs. same field & year
Citations per year
Cited by
Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Vaccine · 2012 · 901 citations
Worldwide burden of cervical cancer in 2008
Annals of Oncology · 2011 · 1,144 citations
References
Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses
Vaccine · 2006 · 544 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.